Sage — Catecholamines (The Kit)
Hypothesis: dopamine · norepinephrine · epinephrine as spend valves on short clocks — orchestra with parasympathetic release, not dualist cartoons.
The Kit · Coach · Surfer · Signals · Fuel toxins
THE METABOLIC HYPOTHESIS OF CATECHOLAMINES
Energy Flux Valves in a Nested Autonomic Orchestra
Frugal Philosophy Essay · September 2026
This essay presents a metabolic and evolutionary hypothesis for educational and philosophical purposes. It is not medical advice, diagnosis, or treatment. Individual circumstances vary; readers should consult a qualified clinician before making significant changes to diet, stimulant use, sleep, or training, especially if they have existing medical conditions or take medications. Nicotine and amphetamines carry well-established harms that are not offset by any metabolic observation in this essay.
The human organism is a nested engine. Mitochondria oxidize preferred substrates into adenosine triphosphate (ATP) on a long, high-capacity clock. Cytosolic glycolysis supplies faster, less efficient on-demand power. The phosphocreatine buffer recycles ATP on a millisecond clock. Those engines do not decide, by themselves, when to open. Something has to match flux to load—to stand, to sprint, to shiver, to think hard, to bleed, to wake. That matching is the work of the catecholamines.
This essay continues the metabolic hypothesis series. Prior pieces argued that fuel is not generic calorie, that beauty is an honest signal of cellular energy systems, that chronic disease is often compensatory mode in a biology tuned for ancestral entrainment, and that the EnSurf architecture—Fuel, Circadian alignment, and Strength hormesis—repairs the engine rather than the dashboard. Catecholamines belong in that architecture as the short-timescale valves of energy flux. They are not a separate mood chemistry. They are not merely the “fight-or-flight hormones.” They are how a holobiont spends ATP in the next seconds and minutes, and how it decides whether spending is worth it.
The hypothesis is straightforward. Dopamine, norepinephrine, and epinephrine form a single biosynthetic ladder from tyrosine, and each rung is a different spatial and temporal strategy for allocating energy. Dopamine forecasts whether expenditure will pay. Norepinephrine opens regional valves at nerve endings. Epinephrine broadcasts a whole-organism demand signal from the adrenal medulla. The parasympathetic nervous system is not an independent opposing government; it is the other half of one orchestra, conducted from the brainstem, that must release the valves, restore vagal tone, and permit overnight repair. Brown adipose tissue is the visible mitochondrial expression of that sympathetic valve at fat. Pharmacologic mimics—caffeine, nicotine, amphetamines—can open the valves without matching demand to capacity. Health is a large, clean pulse and a fast return to a low baseline, sitting on a fat-capable mitochondrial base and a night that is actually a fast.
The Nested Engine and the Job of a Valve
I think of the body as a meta-engine that generates power on multiple timescales. Mitochondrial oxidative phosphorylation is the nuclear reactor: bulk base energy, preferred fuel of fat and ketones, hours to days of capacity when membranes, redox, and oxygen are intact. Cytoplasmic glycolysis is the gas turbine: mid-range, more primitive, preferred fuel of glucose, recruited when load exceeds what the reactor can deliver in time. The creatine–phosphate system is the hybrid battery: cells saturated from dietary meat, charged by adding a phosphate, emptied almost instantly when ATP becomes adenosine diphosphate (ADP).
Cortisol modulates energy availability on a moderate clock with a twenty-four-hour envelope. Testosterone and the other sex steroids tell muscle how much structural load the engine is allowed to carry. Adenosine monophosphate (AMP) and the AMP-activated protein kinase (AMPK) axis tell the cell how many mitochondrial engines to build and which to recycle. Mechanistic target of rapamycin (mTOR) estimates future load and builds structure. Inflammation, when chronic, is the signal that load has exceeded capacity for too long.
Catecholamines and the autonomic nerves that release them occupy the shortest endocrine–neural clock that still coordinates the whole animal. They do not invent ATP capacity. They decide, right now, which engines open, which substrates leave the warehouse, and which tissues receive first claim on oxygen and fuel. A physiology that treats them as psychiatric ornaments or as isolated “stress chemicals” misses the upstream job.
One Ladder, Three Strategies
Dopamine, norepinephrine, and epinephrine are built from the same amino acid, tyrosine, in four enzymatic steps. Tyrosine hydroxylase, requiring ferrous iron, tetrahydrobiopterin (BH4), and molecular oxygen, converts tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA). This is the rate-limiting gate. Aromatic L-amino acid decarboxylase, requiring vitamin B6, converts L-DOPA to dopamine. Dopamine β-hydroxylase, requiring vitamin C and copper and living inside vesicles, converts dopamine to norepinephrine. Phenylethanolamine N-methyltransferase, largely adrenal and cortisol-supported, converts norepinephrine to epinephrine.
That ladder is already an energy-allocation map. Most of the brain stops at dopamine. Sympathetic terminals stop at norepinephrine. Only the adrenal medulla, under cortical permission, takes the last step and dumps epinephrine into blood. Local precision first; systemic broadcast when the whole organism must raise flux.
Dopamine is not adequately described as a reward chemical. Reward is one readout of a more general job: allocate effort and exploration according to predicted energetic return. Midbrain dopamine neurons integrate metabolic state—insulin, leptin, ghrelin, incretins, nutrient signals—and set vigor, initiation, and willingness to spend ATP. Tonic dopamine supports the sense that energy is available. Phasic bursts mark that a particular action paid. Collapse of tonic dopamine feels like anhedonia and like low energy because the organism has decided the expected return on expenditure is poor. Effort itself—hard training, cold, finishing a difficult task—raises dopamine. That rise can feel like energy independently of calories. It is neuromodulatory flux, not caloric flux. The two remain coupled because a healthy dopamine system only keeps spending if mitochondria can cash the check.
Peripheral dopamine is even more plainly metabolic. Proximal tubule cells take up circulating L-DOPA and decarboxylate it to dopamine that is natriuretic and helps restrain nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Infused dopamine at sufficient rates is calorigenic. Gut and pancreas express dopamine receptors that sit on the same energy-allocation board as the outer symbiont in the fuel essay. Dopamine’s role in energy flux is decision and routing.
Norepinephrine is the point-to-point sympathetic cable. It is released from varicosities onto heart, vessel, fat pad, and brown adipose tissue. Most of what is released is recaptured by the norepinephrine transporter; plasma norepinephrine is overflow, not the primary signal. Receptor bias favors alpha-1, alpha-2, and beta-1, with weaker beta-2. The metabolic job at modest concentrations is especially lipolysis—opening the fat warehouse that the mitochondrial reactor prefers. The vascular job is to defend pressure and redirect flow.
Epinephrine is the public-address system. Chromaffin cells of the adrenal medulla release it into blood so every beta-2-bearing tissue hears the same alarm. Epinephrine is the stronger glycogenolytic and hyperglycemic agent and the stronger raiser of whole-body metabolic rate. Norepinephrine raises regional flux without necessarily flipping the organism off fat oxidation. Epinephrine is more willing to force the glycolytic turbine so brain and fast-twitch muscle can keep running if the threat lasts more than a few seconds.
Plasma half-lives of the free amines are on the order of one to three minutes. Tissue action fades over minutes. That is the correct clock for a valve. Health is not a high average catecholamine level. Health is amplitude: a large, clean pulse and a fast return to a low baseline—the same shape this series already insists on for the cortisol curve.
L-DOPA: Intermediate, Index, and Contested Modulator
L-DOPA is made in the cytosol of catecholamine-producing cells: substantia nigra and ventral tegmental area, hypothalamic dopaminergic neurons, locus coeruleus, sympathetic postganglionic neurons, and adrenal chromaffin cells. Tyrosine is rarely the bottleneck at rest. Iron, BH4, oxygen, and the phosphorylation state of tyrosine hydroxylase are. Activity-dependent phosphorylation lifts end-product inhibition. Cytosolic dopamine and norepinephrine bind the iron site and inhibit the enzyme—the short negative feedback. Autoreceptors reduce cyclic adenosine monophosphate (cAMP)–dependent phosphorylation of the enzyme. Stress, cold, and nicotine induce the enzyme over hours to days.
Aromatic L-amino acid decarboxylase is fast and widely expressed. Circulating L-DOPA is a real pool, higher in plasma than dopamine or epinephrine, with arteriovenous increments across many organs. The kidney uses that circulating precursor to make local dopamine. Almost all urinary dopamine is made this way. The body therefore treats L-DOPA as a transportable intermediate that lets tissues without tyrosine hydroxylase still participate in the flux conversation.
L-DOPA is not the long-timescale analogue of the catecholamines. Cortisol, thyroid hormone, and transcriptional induction of tyrosine hydroxylase are. Plasma L-DOPA is a useful index of how hard the catecholamine factory is running. A minority literature argues that L-DOPA itself can act as a local neuromodulator in some circuits. Even if that holds, it remains a seconds-to-minutes signal, not a days-long endocrine set point. The long loops are enzyme induction, receptor trafficking, and the cortisol permission structure that supports adrenal phenylethanolamine N-methyltransferase.
Brown Adipose Tissue: The Color of Mitochondria
Brown adipose tissue is brown because it is dense with mitochondria, and those mitochondria are dense with iron-containing heme of the cytochromes in the electron transport chain. White adipocytes store; they carry few mitochondria and one large lipid droplet. Brown adipocytes are packed with smaller droplets and with large, cristae-rich mitochondria. The heme cofactors of cytochrome oxidase, together with a rich capillary bed, give the tissue its color. Beige or brite adipocytes, inducible within white depots, take on a lighter brown as mitochondrial density rises.
Color here is not cosmetic. It is a visible index of the same inner symbiont this series treats as the nuclear reactor—except that in brown fat the reactor is deliberately uncoupled. Uncoupling protein 1, also called thermogenin, lets protons re-enter the matrix without making ATP. Substrate is oxidized; the gradient becomes heat. Sympathetic norepinephrine at beta-3 receptors is the physiologic switch. Cold, some exercise, and certain dietary and circadian patterns recruit this tissue. Infants depend on it. Adults retain depots, especially in the neck and supraclavicular fossae, in amounts that vary with age, adiposity, and recent thermal history.
Brown fat is therefore not a side curiosity. It is catecholamine-gated mitochondrial flux expressed as heat rather than as work. When the valve is used in brief, recovered pulses—cold, movement, a cold night after a fed day—it is hormesis talking to peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and to membrane remodeling. When sympathetic tone is high and flat, the same receptors see a stuck alarm rather than a training signal.
An Orchestra, Not Independent Systems
The sympathetic and parasympathetic limbs are taught as opposites: fight or flight versus rest and digest. That classroom cartoon is useful for a first hour and then becomes an obstacle. They are sections of one orchestra, conducted from the medulla, playing on shared viscera with reciprocal, prejunctional, and reflex coupling.
Afferents from arterial baroreceptors, chemoreceptors, atrial stretch receptors, and the gut travel via the vagus and glossopharyngeal nerves to the nucleus tractus solitarius (NTS) in the brainstem. The NTS is the score desk. It talks to the rostral ventrolateral medulla to set sympathetic premotor tone, to the nucleus ambiguus and dorsal motor nucleus of the vagus to set parasympathetic outflow, and upward to hypothalamus and amygdala so metabolic state and threat can retune the piece. Standing up is not “sympathetic on, parasympathetic off” as two separate decisions. It is one baroreflex that withdraws vagal restraint on the sinus node and recruits sympathetic vasoconstriction together.
At the nerve–myocyte interface the coupling is even tighter. Postganglionic parasympathetic terminals release acetylcholine onto muscarinic M2 receptors, slowing the heart and reducing inotropy. The same acetylcholine binds prejunctional muscarinic receptors on sympathetic terminals and inhibits norepinephrine release. Sympathetic activity, in turn, can restrain acetylcholine release. The two sections mute each other at the synapse; they do not merely shout from different balconies.
The metabolic meaning of that architecture is recovery. Catecholamines open valves. Vagal tone closes them, lengthens diastole, supports gut motility and the cephalic phase of insulin, and permits the overnight program this series already assigned to the four-hour pre-sleep feeding window: growth hormone, autophagy, mitophagy, microbial recovery, the cortisol nadir. Heart-rate variability, in the EnSurf frugal dashboard, is not a wellness accessory. It is a readable trace of whether the orchestra can still release the sympathetic section after the passage is over.
Pathways worth naming, because they are the same pathways the fuel and circadian essays already implied: the arterial baroreflex; the chemoreflex that raises sympathetic outflow when oxygen falls or carbon dioxide rises; vagal afferents from gastric distension and intestinal nutrients that inform the NTS about incoming fuel; the cholinergic anti-inflammatory reflex; and central adrenergic tone from the locus coeruleus that sets arousal gain for the whole score. Dopamine sits partly outside this pair as the bid–ask spread on whether the orchestra should play a loud movement at all.
They are not independent systems. A high-catecholamine physiology that cannot restore vagal tone is not “strong sympathetic.” It is a one-section band that never leaves fortissimo. That is the autonomic version of a flattened cortisol curve and of late eating that never permits a fast.
Timescales, and the Analogues That Rhyme
Milliseconds to seconds: vesicular release, synaptic dopamine and norepinephrine, the phosphocreatine buffer already emptying. Seconds to two minutes: circulating epinephrine and norepinephrine peak; heart rate, bronchodilation, glycogenolysis, immediate lipolysis. Minutes to hours: residual elevation after strong stimuli—cold can keep dopamine and norepinephrine up for hours without the crash of a drug spike—and the first transcriptional seeds of PGC-1α and hormone-sensitive lipase. Hours to a day: vesicular stores turn over; tyrosine hydroxylase phosphorylation and induction refill the factory; adrenal epinephrine synthesis waits on the cortisol permission structure.
The same job—mobilize, match, recover—repeats on slower clocks. Cortisol is energy mobilization across the day; the morning cortisol awakening response is the daily opening of the reactor, and the nocturnal nadir is permission to repair. Insulin stores; glucagon dumps hepatic substrate. Triiodothyronine sets the gain of the reactor over days to weeks. Growth hormone mobilizes fat and supports overnight repair. Sex steroids tell muscle and bone how much structure to keep and change adrenergic receptor expression in fat. AMPK and PGC-1α are the cell-autonomous accountants of insufficient engines. Chronic inflammatory cytokines are the stuck alarm that load has exceeded capacity.
The fractal rule is the same at every scale: short pulse, high amplitude, fast return. Catecholamines do it in seconds. Cortisol does it across the day. Thyroid and sex steroids do it across seasons and life stages. When any layer stays high and flat, the system interprets perpetual emergency, stores rather than fluxes, and the honest signals of fitness degrade because surplus can no longer be spent on costly traits.
Caffeine, Nicotine, and Amphetamines: Stolen Valves
These three raise catecholamine signaling by breaking into different doors. None of them changes the mitochondrial preference for fat and ketones. They change whether the valves open and whether the organism can hear fatigue.
Caffeine, at ordinary doses, is an antagonist at adenosine A1 and A2A receptors. Adenosine accumulates as ATP is spent; it is a local energy-debt signal. A2A receptors form heteromers with dopamine D2 receptors in striatum; adenosine on A2A makes D2 less effective. Block A2A and the same dopamine works better. Presynaptic A1 blockade lifts a brake on dopamine and norepinephrine release. The result is a modest, permissive rise in catecholamine signaling, alertness, circulating epinephrine, and free fatty acids. Phosphodiesterase inhibition requires concentrations well above a cup of coffee and belongs to toxicity. Caffeine hides the debt meter. If the reactor is solvent, that is useful. If the organism is already in debt, the afternoon crash and the night pay the bill. Habitual use upregulates adenosine receptors; the same dose eventually only restores baseline.
Nicotine is an agonist at nicotinic acetylcholine receptors. On adrenal chromaffin cells, principally alpha-3 beta-4 receptors, it evokes real exocytosis of epinephrine more than norepinephrine—the same synapse the splanchnic nerve uses. In brain, alpha-4 beta-2 and other receptors on ventral tegmental dopamine neurons and on circuits that drive sympathoadrenal outflow raise central dopamine and plasma catecholamines. Receptors desensitize within minutes. Chronic exposure induces adrenal tyrosine hydroxylase and dopamine β-hydroxylase, remodeling synthetic capacity, not merely acute release.
Does nicotine play a role in body composition? Yes, and the role is real enough to have misled both smokers and the culture around them. Nicotine suppresses appetite, raises resting metabolic rate, increases lipolysis, and can promote brown-fat thermogenesis and some browning of white fat through sympathetic activation and hypothalamic circuits. Adult smokers, on average, weigh less than matched nonsmokers. Cessation is followed by a typical gain on the order of four to five kilograms over the first year, with wide variance and larger gains in heavier people and heavier smokers. That is the withdrawal of a stolen thermogenic and anorectic valve, plus restored smell and taste, plus a hypodopaminergic window that favors hedonic eating.
It is not a composition strategy. Smoking also promotes insulin resistance, endothelial injury, and a pattern of central fat that is metabolically worse than the scale suggests. The lower body weight of the smoker is not the lean, mitochondria-rich composition this series treats as an honest signal. It is a dirty, incomplete flux signal purchased with vascular and genomic toxicity. The EnSurf implication is the opposite of a recommendation: when the stolen valve is removed, Fuel, Circadian alignment, and Strength hormesis must carry the flux that nicotine was counterfeiting. Cessation without engine repair is why the dashboard weight rises and why fear of that rise keeps people smoking.
Amphetamines ride the dopamine and norepinephrine transporters inward and reverse them. Inside the terminal they collapse the vesicular proton gradient at vesicular monoamine transporter 2, dump stored amine into cytosol, and send it out through the reversed plasma-membrane transporter. Newly synthesized cytosolic dopamine is a preferred substrate for that efflux. The pulse is huge and uncoupled from actual work. Heart rate, lipolysis, glycogenolysis, thermogenesis, and vigor jump; appetite falls. Then stores are depleted, transporters internalize, tyrosine hydroxylase is inhibited by cytosolic dopamine, and physiologic pulses cannot refill the cleft. That is a counterfeit high-flux state that mortgages the reservoir the autonomic layer needs for real load.
Ranking the distortion: caffeine borrows minutes to a few hours from adenosine accounting; nicotine fires a true minutes-long sympathoadrenal volley and, with repetition, remodels enzymes over days; amphetamines force minutes of overflow and tax synthetic and vesicular capacity for hours to days. None replaces sleep, a cortisol nadir, or a mitochondrial base running on proper fuel.
How Catecholamines Sit Inside EnSurf
Fuel still wins. Catecholamines mobilize whatever is in the warehouse. If the warehouse is appropriate fat and the redox context is clean, beta-oxidation and ketogenesis rise and reactive oxygen species stay controlled. If the warehouse is glucose-locked by hyperinsulinemia and membranes are linoleic-rich, the same norepinephrine and epinephrine pulse produces more glycolysis, more leak, more lactate, and a messier recovery—the compensatory cascade already described in the metabolic hypothesis of fuel.
Circadian timing is the permission structure. Phenylethanolamine N-methyltransferase, tyrosine hydroxylase phosphorylation, adrenal sensitivity, receptor trafficking, and the nightly restoration of vagal tone all ride the cortisol–light–sleep axis. A robust morning cortisol awakening response plus a nocturnal nadir makes the next day’s catecholamine pulses cheaper and shorter. Late eating and nocturnal insulin keep the mobilization system slightly on all night and blunt the parasympathetic movement that should close the piece.
Strength hormesis is a catecholamine language. Resistance loading, sprints, cold, heat, and carbon-dioxide stress are brief, high-amplitude pulses of norepinephrine, epinephrine, and dopamine followed by mitochondrial and vascular remodeling. That is how the autonomic layer talks to PGC-1α and AMPK. Chronic psychosocial sympathetic drip without mechanical or thermal work is the counterfeit version: the same transmitters, none of the engine upgrade.
The outer symbiont is not separate. Enteric and renal dopamine, vagal afferents from the gut, and short-chain fatty acids from fermented microbiota-accessible carbohydrates sit on the same allocation board. Barrier failure and metabolic endotoxemia keep a low-grade sympathetic and cytokine alarm running—another flattened, expensive pulse.
Frugal Restoration and Testable Predictions
If catecholamines are flux valves in an orchestra rather than isolated stress chemicals, then the highest-leverage repairs are the ones this series already named. Prioritize animal fats and proteins as the primary mitochondrial fuel so mobilized substrate can be oxidized cleanly. Feed the biota with fermented microbiota-accessible carbohydrates and mushrooms. End the feeding window at least four hours before sleep so the cortisol decline, the growth-hormone pulse, and vagal recovery can proceed. Train with real load. Use cold and heat as brief pulses, not as lifestyle drip. Treat caffeine as a timed tool, not as a substitute for sleep. Do not use nicotine or amphetamines as body-composition or productivity strategy.
The readable traces are already on the EnSurf frugal dashboard. Grip strength and a VO₂ max proxy estimate ATP-generating capacity. Waist-to-height and lean mass estimate whether flux became structure. The shape of the cortisol curve estimates circadian permission. Resting heart rate, heart-rate variability, nocturnal blood-pressure dipping, and sleep architecture estimate whether the parasympathetic section can still play. A high-catecholamine life with low heart-rate variability, a flat cortisol curve, and rising visceral fat is not a high-flux life. It is a valve stuck open over a reactor that cannot keep up.
The testable predictions are simple. Individuals who restore Fuel, Circadian alignment, and Strength hormesis should show larger diurnal autonomic amplitude—higher daytime pulse capacity, lower nocturnal sympathetic tone, higher heart-rate variability—without needing higher average plasma catecholamines. Brown-fat activity, where measurable, should track recent cold and fitness more than it tracks stimulant use. Cessation of nicotine without engine repair should raise fat mass; cessation with engine repair should raise lean quality and vagal markers even if the scale moves. Amphetamine-shaped days should look, on overnight traces, like incomplete recovery. Beauty cues and the other honest signals of cellular fitness should improve when pulses are large and recoveries are real, because only then is there surplus to spend on costly traits.
Boundaries
No performance stacks (caffeine/nicotine/amphetamines). Do not diagnose “low dopamine” from wearables. Board-first: Fuel · Circadian · Strength before pharmacologic valve control.
A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 17, 2026.